GlassScriptPhysician profile
Neda Shamie
NPI 1396837282
$546,651.07
in general payments reported to CMS, 2019-2025
35 companies · $96K in 2025
The $96K reported for 2025 was more than what 99% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95K · 2020: $11K · 2021: $196K · 2022: $61K · 2023: $49K · 2024: $39K · 2025: $96K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $156K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Food and Beverage: $8,113 · Travel and Lodging: $5,418 · Long Term Medical Supply Or Device Loan: $62.95 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $155,975.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,625.00 |
| Food and Beverage | $8,112.78 |
| Travel and Lodging | $5,418.22 |
| Long Term Medical Supply Or Device Loan | $62.95 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $231,111.07 | 2019-2022 | |
| Alcon Vision LLC | $189,532.39 | 2019-2025 | Clareon, Acrysof Iq Vivity, Acrysof Iq Panoptix Uv Iol |
| Alcon Research LLC | $42,076.11 | 2021-2025 | Lensx, Unity, Ngenuity |
| Lensar, INC. | $19,488.82 | 2020-2025 | Lensar Laser System |
| Rxsight INC | $14,422.85 | 2021-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Tarsus Pharmaceuticals, INC. | $10,279.11 | 2024-2025 | Xdemvy |
| Glaukos Corporation | $8,973.48 | 2019-2025 | Iaccess Precision Blade, Photrexa Viscous and Photrexa, Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Avedro INC. | $8,000.00 | 2019 | |
| Sight Sciences, INC. | $5,257.14 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Eyevance Pharmaceuticals LLC | $3,363.68 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $2,528.65 | 2019-2021 | |
| Abbvie INC. | $1,864.64 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $1,670.66 | 2019-2023 | Axert, Tecnis Iol |
| Carl Zeiss Meditec USA, INC. | $1,652.47 | 2022-2024 | Visumax, Quatera 700, Iolmaster 700 |
| Carl Zeiss Meditec, INC. | $1,516.58 | 2020-2025 | Cirrus Hd-Oct, Callisto Eye, Iolmaster 700 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $1,354.31 | 2022-2023 | Rayone Emv, Rayone Spheric, Rayone Aspheric |
| Stryker Corporation | $1,352.00 | 2019 | |
| Bausch & Lomb Americas INC. | $575.26 | 2023-2025 | Stellaris Elite, Teneo, Envista Aspire Iol |
| Sun Pharmaceutical Industries INC. | $426.97 | 2019-2025 | |
| Oyster Point Pharma, INC. | $340.37 | 2022-2023 | Tyrvaya |
| Harrow Eye, LLC | $221.52 | 2025 | Vevye |
| Nova Eye, INC. | $134.62 | 2025 | |
| Beaver-Visitec International, INC. | $111.93 | 2025 | |
| Omeros Corporation | $86.78 | 2021 | |
| Staar Surgical Company | $77.13 | 2019 | |
| Brainsway USA INC | $67.55 | 2021 | |
| Biotissue Holdings INC. | $31.02 | 2024-2025 | |
| Ivantis, INC | $23.85 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $20.80 | 2019 | |
| Horizon Therapeutics Plc | $20.60 | 2023 | Tepezza |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| New World Medical,INC. | $17.36 | 2020 | |
| Dompe US, INC. | $16.78 | 2024 | Oxervate |
| Halozyme INC | $14.34 | 2025 | Hylenex Recombinant |
| Travere Therapeutics, INC. | $0.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neda Shamie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.